Loading…
Loading grant details…
| Funder | EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT |
|---|---|
| Recipient Organization | Columbia University Health Sciences |
| Country | United States |
| Start Date | Jul 23, 2024 |
| End Date | Mar 31, 2029 |
| Duration | 1,712 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10779608 |
Project Summary/Abstract The genome of the early embryo provides the genetic information of the adult and thereby determines the health of a person. Surprisingly, though an intact genome is paramount to normal development, the genome of some mammalian species is highly unstable, including in human. Cleavage-stage embryos acquire high levels
of DNA damage and frequent chromosomal abnormalities that adversely affect developmental potential. We recently showed that the key reason for these abnormalities are high levels of DNA replication stress during the first cell cycles. The causes of replication stress are not known, and we are only beginning to understand
the consequences. Therefore, there is a strong rationale to study DNA replication in the mammalian embryo. A hypothesis central to this proposal is that DNA replication stress is caused by epigenetic remodeling during the first cell cycles. We furthermore hypothesize that the dynamics of DNA replication, also called DNA
replication timing, predispose specific genomic regions to instability and chromosome breakage. We will test this hypothesis in three specific Aims. In Aim1, we will identify the causes of DNA replication stress. In Aim2, we will characterize replication timing during preimplantation development, identify its molecular determinants
in the preimplantation embryo, and correlate these with the sites of chromosome breakage determined in Aim3. The proposed work is innovative, because it focuses on an essential process - the replication of the DNA - that has thus far not been examined as a developmentally relevant factor in mammals, and which has not yet
been investigated as a source of genetic change. It is also innovative because of the use of animal model systems which accurately reproduce the defects seen in human cells. The contribution is significant, because the proposed studies will lead to an understanding of the causes, mechanisms, and consequences of genome instability in the first few cell divisions of mammalian
development. The work proposed will help understand the source of both normal as well as disease-causing genetic variation in the genome.
Columbia University Health Sciences
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant